EUVIMEDEUVIMED entdecken
Crossref

Enhancing oocyte competence in patients with polycystic ovarian syndrome: A microfluidic study on the effects of follicular fluid meiosis‐activating sterol in in vitro oocyte maturation

Hossein Torkashvand iD, Ronak Shabani, Tayebe Artimani, Shamim Pilehvari, Mahdi Moghimi, Leila Torkashvand, Mahnaz Ashrafi, Mehdi Mehdizadeh

Journal of Obstetrics and Gynaecology Research · 2025-01 · 51 (1)

DOI: 10.1111/jog.16203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 21.01.2025. Verfasst von Hossein Torkashvand und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, In Vitro Oocyte Maturation Techniques, Follicular Fluid, Oocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Iran University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the efficacy of a microfluidic culture system supplemented with follicular fluid meiosis‐activating sterol (FF‐MAS) on the maturation of immature oocytes in patients with polycystic ovarian syndrome (PCOS).

Methods

A total of 438 germinal vesicle oocytes from 163 PCOS patients were included. Oocytes were divided into five groups: (1) cultured in static drops without FF‐MAS, (2) cultured in static drops with FF‐MAS, (3) cultured in a microfluidic device without FF‐MAS, (4) cultured in a microfluidic device with FF‐MAS for the first 2 h, and (5) cultured in a microfluidic device with FF‐MAS for 24 h. Maturation, fertilization, and embryo development rates were assessed, alongside gene expression analysis using quantitative real‐time PCR. Ultrastructural analysis was performed using transmission electron microscopy (TEM).

Results

The maturation rates for oocytes in groups 1 to 5 were 36%, 48%, 42%, 64%, and 65%, respectively, with groups 4 and 5 showing significant increases ( p < 0.05). Fertilization rates were higher in groups 4 and 5 (p < 0.05). High‐quality embryo formation rates were significantly higher in groups 3, 4, and 5. Gene expression analysis indicated enhanced expression of BRCA1 and TP53 in the dynamic culture groups. Ultrastructural analysis showed improved mitochondrial integrity and cytoplasmic maturation in the dynamic groups.

Conclusions

The dynamic microfluidic culture system with FF‐MAS supplementation significantly enhances oocyte maturation and embryo quality in PCOS patients by closely mimicking the natural in vivo environment. This approach shows promise for optimizing in vitro oocyte maturation and improving fertility outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeIn Vitro Oocyte Maturation TechniquesFollicular FluidOocytesMeiosisSterolsHumansFemaleAdultLab-On-A-Chip DevicesFertilization in VitroEmbryonic Development

Stichwörter der Autor:innen

FF‐MASPCOSin vitro maturationmicrofluidic devicesoocytes

Substanzen

Sterols

Autor:innen und Institutionen

  • Department of Anatomy, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Fertility and Infertility Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Reproductive Sciences and Technology Research Center, Department of Anatomy, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • School of Mechanical Engineering, Iran University of Science and Technology, Tehran, Iran.
  • Reproductive Sciences and Technology Research Center, Department of Obstetrics and Gynecology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Hossein Torkashvand

Förderung

  • Iran University of Medical Sciences

Zitieren

APA

Torkashvand, H., Shabani, R., Artimani, T., Pilehvari, S., Moghimi, M., Torkashvand, L., Ashrafi, M., & Mehdizadeh, M. (2025). Enhancing oocyte competence in patients with polycystic ovarian syndrome: A microfluidic study on the effects of follicular fluid meiosis‐activating sterol in in vitro oocyte maturation. Journal of Obstetrics and Gynaecology Research, 51(1). https://doi.org/10.1111/jog.16203

Vancouver

Torkashvand H, Shabani R, Artimani T, Pilehvari S, Moghimi M, Torkashvand L, et al. Enhancing oocyte competence in patients with polycystic ovarian syndrome: A microfluidic study on the effects of follicular fluid meiosis‐activating sterol in in vitro oocyte maturation. Journal of Obstetrics and Gynaecology Research. 2025;51(1). doi:10.1111/jog.16203

BibTeX
@article{Torkashvand2025,
  author = {Torkashvand, Hossein and Shabani, Ronak and Artimani, Tayebe and Pilehvari, Shamim and Moghimi, Mahdi and Torkashvand, Leila and Ashrafi, Mahnaz and Mehdizadeh, Mehdi},
  title = {Enhancing oocyte competence in patients with polycystic ovarian syndrome: A microfluidic study on the effects of follicular fluid meiosis‐activating sterol in in vitro oocyte maturation},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2025},
  volume = {51},
  number = {1},
  doi = {10.1111/jog.16203}
}
Kostenlos starten →